| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -2,040,902 |
| Stock based compensation | 0 |
| Restricted stock expense | 14,121 |
| Issuance of stock for services | 86,657 |
| Inventory and materials impairment | 365,979 |
| Intangibles amortization | 765,078 |
| Depreciation | 361,063 |
| Credit losses | 382,588 |
| Increase/(decrease) in contingent liability | 0 |
| (decrease) increase in fair value of convertible debt | 87,380 |
| Gain on termination of operating lease | 0 |
| Amortization of operating lease asset | 669,781 |
| Accounts receivable | 439,565 |
| Deposits | 0 |
| Inventory | 732,919 |
| Prepaid inventory | 55,789 |
| Prepaid expenses and other current assets | -126,051 |
| Accounts payable and accrued expenses | -261,883 |
| Operating lease liability | -608,354 |
| Deferred revenue / customer deposits | 3,099 |
| Cash used by operating activities | -1,452,375 |
| Purchase of intangible assets | 0 |
| Purchase of property and equipment | 184,172 |
| Cash used by investing activities | -184,172 |
| Proceeds from issuance of common stock | 0 |
| Note payable | 0 |
| Proceeds from issuance of preferred stock | 1,445,236 |
| Cash provided by financing activities | 1,445,236 |
| Net (decrease) increase in cash | -191,311 |
| Cash and cash equivalents at beginning of period | 2,452,553 |
| Cash and cash equivalents at end of period | 2,261,242 |
cbdMD, Inc. (YCBD)
cbdMD, Inc. (YCBD)